Using Modified Liver Cells to Treat Diabetes in Pigs
Author Information
Author(s): Chen Nelson K. F., Wong Jen San, Kee Irene H. C., Lai Siang Hui, Thng Choon Hua, Ng Wai Har, Ng Robert T. H., Tan Soo Yong, Lee Shu Yen, Tan Mark E. H., Sivalingam Jaichandran, Chow Pierce K. H., Kon Oi Lian
Primary Institution: National Cancer Centre, Singapore
Hypothesis
Can autologous hepatocyte implants correct diabetes and prevent organ injury in a preclinical model?
Conclusion
The study shows that modified liver cells can effectively manage diabetes and prevent related organ damage in pigs.
Supporting Evidence
- Modified hepatocytes showed sustained insulin secretion for at least 47 weeks.
- Treatment significantly improved glycemic control in diabetic pigs.
- 70% of implanted hepatocytes functionally engrafted and expressed human insulin.
Takeaway
Scientists took liver cells from pigs, changed them to produce insulin, and put them back in the pigs to help control their diabetes.
Methodology
Hepatocytes were isolated, electroporated with an insulin expression vector, and reimplanted into diabetic pigs.
Limitations
The study was conducted in a preclinical model, which may not fully translate to human patients.
Participant Demographics
Diabetic Yorkshire pigs were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website